Tao Luo

Chongqing Medical University

H指数:29

被引数:2,572

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combined application of the modified early warning score and the modified hematoma expansion prediction score for predicting hematoma expansion in intracerebral hemorrhage

改良早期预警评分与改良血肿扩大预测评分联合应用预测脑出血血肿扩大

Scientific Reports

IF3.9

2026-05-300

OAAI

NSUN3 promotes oral squamous cell carcinoma progression through autophagy activation and FOXO pathway modulation

NSUN3通过自噬激活和FOXO通路调控促进口腔鳞状细胞癌进展

Frontiers in Oncology

IF3.3

2026-04-220

OAAI

Association between triglyceride glucose index trajectory and risk of hypertension in rural residents: a prospective cohort study

三酰基葡萄糖指数轨迹与农村居民高血压风险之间的关联：一项前瞻性队列研究

Scientific Reports

IF3.9

2025-11-050

OAAI

Association Between Serum Advanced Glycation End Products and Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A 3-Year Longitudinal Cohort Study (2019–2022)

血清高级糖化终产物与心血管-肾脏-代谢综合征(CKM)的关系：一项为期3年的纵向队列研究(2019–2022)

Journal of Diabetes

IF3.7

2025-08-210

OAAI

Enhancing ablation outcomes: vein of Marshall ethanol infusion in persistent atrial fibrillation with severe left atrial enlargement

增强消融效果：持续性心房颤动伴严重左心房扩大患者的马歇尔静脉乙醇灌注

FRONTIERS IN CARDIOVASCULAR MEDICINE

IF2.9

2025-04-100

Endothelial α1-adrenergic receptor activation improves cardiac function in septic mice via PKC-ERK/p38MAPK signaling pathway

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-11-010

OAAI

Psychotic symptoms associated increased CpG methylation of metabotropic glutamate receptor 8 gene in Chinese Han males with schizophrenia and methamphetamine induced psychotic disorder: a longitudinal study

SCHIZOPHRENIA

IF4.1

2024-10-090

OAAI

Advanced Wound Healing and Scar Reduction Using an Innovative Anti-ROS Polysaccharide Hydrogel with Recombinant Human Collagen Type III

使用创新的抗ROS多糖水凝胶和重组人III型胶原蛋白，先进的伤口愈合和疤痕减少

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2024-09-100

PRE

NEO-PIONEER: Neoadjuvant hypofractionated radiotherapy plus tislelizumab with anlotinib followed by adjuvant tislelizumab with anlotinib in patients with resectable non-small cell lung cancer (NSCLC): A phase II trial in progress

NEO-PIONEER：可切除非小细胞肺癌（NSCLC）患者的新辅助低分割放射治疗联合替雷利珠单抗（tislelizumab）与安洛替尼（anlotinib），随后进行辅助替雷利珠单抗（tislelizumab）与安洛替尼（anlotinib）治疗的II期临床试验。

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

BCL-3 Promotes Intracerebral Hemorrhage Progression by Increasing Blood-Brain Barrier Permeability, Inflammation, and Cell Apoptosis via Endoplasmic Reticulum Stress

MEDIATORS OF INFLAMMATION

IF4.2

2023-09-132

OAAI

Atrial Fibrillation Is Associated With Decreased Claudin-5 In Cardiomyocyte

CIRCULATION RESEARCH

IF16.2

2023-08-040

PRE

( 2R, 6R)Hydroxynorketamine Prevents Myocardial Ischemia Reperfusion Injury By Regulating Immune And Inflammatory Response

CIRCULATION RESEARCH

IF16.2

2023-08-040

PRE

Deficiency Of Claudin-5 Leads To Myocardial Atrophy And Dilation In Mouse Heart With Severe Mitochondrial Dysfunction And Electrical Dissociation

CIRCULATION RESEARCH

IF16.2

2023-08-040

PRE

miR-20a-5p contributes to osteogenic differentiation of human dental pulp stem cells by regulating BAMBI and activating the phosphorylation of Smad5 and p38 (vol 12, 421, 2021)

miR-20a-5p通过调节BAMBI并激活Smad5和p38的磷酸化而促进人牙髓干细胞的成骨分化 (vol 12，421，2021)

STEM CELL RESEARCH & THERAPY

IF7.3

2022-04-290

OAAI

Features of Psychotic Symptoms in Methamphetamine Use Disorder Patients and Ketamine Use Disorder Patients: A Cross-Sectional Study

FRONTIERS IN PSYCHIATRY

IF3.2

2022-01-181

OAAI

Successful Treatment of an Elderly Patient With Combined Small Cell Lung Cancer Receiving Anlotinib: A Case Report

FRONTIERS IN ONCOLOGY

IF3.3

2021-11-114

OAAI

A Novel Role of Claudin-5 in Prevention of Mitochondrial Fission Against Ischemic/Hypoxic Stress in Cardiomyocytes

CANADIAN JOURNAL OF CARDIOLOGY

IF5.3

2021-10-0112

OAAI

miR-20a-5p contributes to osteogenic differentiation of human dental pulp stem cells by regulating BAMBI and activating the phosphorylation of Smad5 and p38

miR-20a-5p通过调节BAMBI和激活Smad5和p38的磷酸化促进人牙髓干细胞的成骨分化

STEM CELL RESEARCH & THERAPY

IF7.3

2021-07-2217

OAAI

Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-03-0421

OAAI

Potential False-Positive and False-Negative Results for COVID-19 IgG/IgM Antibody Testing After Heat-Inactivation

FRONTIERS IN MEDICINE

IF3

2021-01-185

OAAI

Tao Luo

个人简介

教育背景

工作经历

荣誉奖项

研究方向